4//SEC Filing
KOVEN ANDREW I 4
Accession 0001104659-23-084992
CIK 0001638287other
Filed
Jul 27, 8:00 PM ET
Accepted
Jul 28, 6:19 AM ET
Size
13.8 KB
Accession
0001104659-23-084992
Insider Transaction Report
Form 4
KOVEN ANDREW I
Director
Transactions
- Award
Common Stock
2023-07-27+12,500→ 100,000 total - Award
Common Stock
2023-07-27+87,500→ 87,500 total
Footnotes (3)
- [F1]Represents a grant of restricted stock units ("RSUs") issued to the reporting person under the Issuer's 2022 Equity Incentive Plan. Per the terms of the Amended and Restated Non-Employee Director Compensation Policy, the reporting person elected to defer receipt of the shares of common stock upon the vesting of the RSUs until the earlier of the date that is (i) immediately prior to a Change in Control (as described in the Policy), or (ii) within 60 days following the reporting person's retirement or other separation form service with the Issuer or death, whichever is earlier.
- [F2]50% of the RSUs vested immediately, and the remainder will vest in two equal installments on each subsequent anniversary of the date of grant, subject to continuing service.
- [F3]Vests on the earlier of July 27, 2024 or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to continuing service.
Issuer
NeuroBo Pharmaceuticals, Inc.
CIK 0001638287
Entity typeother
Related Parties
1- filerCIK 0001258673
Filing Metadata
- Form type
- 4
- Filed
- Jul 27, 8:00 PM ET
- Accepted
- Jul 28, 6:19 AM ET
- Size
- 13.8 KB